Philips has announced the next generation of its advanced visualisation workspace—IntelliSpace Portal 12. Launched at the virtual Radiological Society of North America Scientific Assembly and Annual Meeting (RSNA 2020, 29 November–4 December, virtual), IntelliSpace Portal features new AI-assisted quantitative assessment and automatic results generation features to support the diagnostic workflow, including follow-up and communication across cardiology, pulmonology, oncology and neurology. Its AI-assisted pulmonary capabilities include the assessment of complex lung conditions associated with COVID-19.
“In the COVID era, the automatic detection and characterisation of pulmonary infiltrates, especially in viral pneumonia, is very important,” said Hans-Ulrich Kauczor, professor and chairman of radiology at the University of Heidelberg, Heidelberg, Germany. “IntelliSpace Portal’s AI-assisted quantitative assessment capabilities allow general radiologists and residents on call to get the necessary support to help identify COVID pneumonia, which is differentiated from other diagnoses. This also plays a significant role for longitudinal analysis and follow-up.“
“The immediate and complex long-term needs of COVID-19 patients, combined with the growth of elective care, has highlighted the continued need for advanced fully-integrated radiology solutions that support efficient diagnosis, follow-up and communication across multiple clinical domains,” said Calum Cunningham, General Manager of Enterprise Diagnostic Informatics at Philips. “The new generation of IntelliSpace Portal adds numerous AI-enabled features that automatically generate quantitative measurements, simplify workflows, and make radiology data available anywhere it’s clinically relevant in an organization.”
A new clinical software packages for cardiology, launched with IntelliSpace Portal 12, includes MR Cardiac Analysis, which involves pre-processing images to deliver AI-based right ventricle and left ventricle segmentation to ensure accurate volumetric and functional measurements. According to Philips, this enables completion of a full cardiac MRI functional analysis in less than five minutes.
Additionally, Philips has integrated MR Caas 4D Flow Analysis, designed to reduce analysis time and improve reliability of valvular flow quantification. The Caas MR 4D Flow visualises and quantifies blood flow patterns in a patient’s heart and main arteries.
